Alzheimer's research and help, in plain English.
Straight answers for families facing Alzheimer's.
Or tell us where you are
Latest news
Approvals, trial results and policy changes, from established outlets.
-
Alzheimer's disease protein atlas reveals hidden cell-type biology
Alzheimer's disease can affect almost the entire brain, but how different cell types are specifically affected is not fully understood.
-
Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead
A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.
-
Experimental blood test can detect four signs of deadly diseases in an hour
A new diagnostic platform is able to screen for and identify four different diseases—colorectal cancer, glioblastoma, pancreatic cancer and Alzheimer's disease—with a small amount of blood in an hour. …
-
Understanding how inflammation begins so scientists can end it
Chronic inflammation is a major factor in arthritis, type 2 diabetes, Alzheimer's disease and cancer.
-
Bridging the gap between genetic variation and function in brain cells
Research has started to bridge the gap between identifying genetic changes that can increase the risk of brain conditions, such as Alzheimer's, and understanding how they might impact specific cell functions.
Latest research
The newest studies in the library that score 67 or more out of 100 (2,922 of the 32,980 do), with their peer-review status.
-
Avoidable Mortality in Adults With Down Syndrome or With Other Intellectual Disabilities
Among 3381 adults with Down syndrome (1892 male [56.0%]; median [IQR] age at death, 59.5 [54.3-64.2] years), 1589 (47.0%) died from avoidable causes. (+4 more on the study page)
-
Evaluating a primary care pharmacist-led intervention to reduce opioid use for persistent non-cancer pain: the PROMPPT cluster randomised controlled trial protocol
The PROMPPT trial will assess whether review by trained clinical pharmacists working in general practices can support safe opioid reduction without compromising pain management and quality of life. (+1 more on the study page)
-
Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis
Thirty-seven studies were included. (+3 more on the study page)
-
Baseline MRI markers and clinical outcomes during anti-amyloid β therapy: A real-world study in a Japanese dementia center
Baseline medial temporal atrophy was associated with functional decline and microbleeds with ARIA-H. Pretreatment MRI may provide prognostic and safety information during anti-amyloid β therapy. (+4 more on the study page)
-
Midlife and Late-Life Alzheimer Disease Blood Biomarkers and 11-Year Cognitive Decline
Midlife p-tau181 was associated with faster 11-year memory decline beginning 20 years later in the ARIC cohort, which underscores a potentially long prodromal phase of cognitive decline that could precede dementia onset. (+4 more on the study page)
The research library
32,980 studies in plain English across 32 subjects. Each is scored and links to the original paper.
Search and filter the research →
Browse by subject · Links the news suggests that nobody has tested · Conferences and events
A few key figures
Americans age 65+ living with Alzheimer's dementia
Alzheimer's Association, 2025 Alzheimer's Disease Facts and Figures (Alzheimer's & Dementia)Alzheimer's prevalence by age: 85+
Alzheimer's Association, 2025 Facts and FiguresIncrease in U.S. Alzheimer's deaths, 2000-2022
Alzheimer's Association, 2025 Facts and FiguresFamily/unpaid dementia caregivers in the U.S.
Alzheimer's Association, 2026 Alzheimer's Disease Facts and FiguresDementia caregivers who rated emotional stress of caregiving as high or very high
Alzheimer's Association, 2025 Facts and FiguresLifetime cost of care per person with dementia
Alzheimer's Association, 2025 Facts and FiguresPeople living with dementia worldwide
WHO, Dementia Fact SheetShare of dementia cases potentially preventable/delayable via modifiable risk factors
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 2024;404(10452):572-628, Table 1FDA-cleared Lumipulse blood test accuracy for detecting amyloid pathology
FDA press announcement, Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio clearanceWhat the research library says
Each page below is built from the studies in alzhub's library: how many match, what kinds of study they are, and what the papers report in their own words.